Case Study | EU registration of a Biosimilar

July 19, 2022

Have a look at a recent success story of how Asphalion achieved Marketing authorization for a biosimilar medicine for a company located in East Asia that wanted to access the EU market.

Thanks to our extensive track record of over 20 year at Asphalion we can assist you with your all CMC activities, non-CMC specific ones and with all other kind of projects.

CLICK HERE TO SEE THE CASE STUDY IN DETAIL

For further information you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | Medicines for Europe annual conference

Asphalion’s Managing Director, Núria Romero, and Lidia Cánovas, Key Accounts Director will be joining the Medicines for Europe annual conference in Malta next week. The

NEW | MHRA announces new recognition routes

MHRA announces new recognition routes to facilitate safe access to new medicines with seven international partners.
The new recognition routes open additional options for the MHRA to bring cutting-edge medicines faster to UK patients by leveraging the expertise and decision-making of trusted regulatory partners.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting